Results 71 to 80 of about 35,539 (289)

Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Background Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule.
Dong Li   +8 more
doaj   +1 more source

Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestine [PDF]

open access: yesGut, 2002
The safety of infant vaccination has been questioned in recent years. In particular it has been suggested that the measles, mumps, and rubella (MMR) vaccination leads to brain damage manifesting as autism consequent to the development of an "enterocolitis" in the immediate post-vaccination period.To assess if MMR vaccination is associated with ...
Thjodleifsson, B   +5 more
openaire   +3 more sources

Vaccine chronicle in Japan [PDF]

open access: yes, 2013
The concept of immunization was started in Japan in 1849 when Jenner’s cowpox vaccine seed was introduced, and the current immunization law was stipulated in 1948.
Tetsuo Nakayama
core   +1 more source

Therapeutic Potential of Lipid Nanoparticle‐Encapsulated CD19‐Targeting mRNAs in Lupus and Rheumatoid Arthritis

open access: yesAdvanced Science, Volume 12, Issue 21, June 5, 2025.
This study develops lipid nanoparticle‐encapsulated mRNA‐encoding antibodies (mRNab‐LNPs) targeting CD19, demonstrating robust anti‐CD19 antibody production in vivo. Intramuscular injection of mRNab‐LNPs reduces CD19+ B and plasma cells in lupus and rheumatoid arthritis mice, significantly alleviating histopathological changes and tissue injuries of ...
Chipeng Guo   +10 more
wiley   +1 more source

Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA

open access: yesEmerging Infectious Diseases, 2013
Although the measles-mumps-rubella (MMR) vaccine is not recommended for mumps postexposure prophylaxis (PEP), data on its effectiveness are limited. During the 2009–2010 mumps outbreak in the northeastern United States, we assessed effectiveness of PEP ...
A. Fiebelkorn   +4 more
semanticscholar   +1 more source

Towards Measles elimination [PDF]

open access: yes, 2003
In many European countries measles is still a cause of great public health concern. Outbreaks of the disease are still occurring because the degree of vaccination coverage required to interrupt transmission has not yet been achieved.
Muscat, Mark, Sciberras, Maria
core  

Sufficient reproduction numbers to prevent recurrent epidemics

open access: yesMethods in Ecology and Evolution, Volume 16, Issue 6, Page 1186-1200, June 2025.
Abstract Current practice in the design and evaluation of control measures in disease ecology and epidemiology, including vaccination, is largely based on reproduction numbers (RNs), which represent prognostic indices of long‐term disease transmission, both in naïve populations (basic RN) and in the presence of prior exposure or infection containment ...
Lorenzo Mari   +3 more
wiley   +1 more source

The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: A retrospective cohort study

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Objectives: To evaluate the effectiveness of the measles-mumps-rubella (MMR) vaccine in reducing hospitalizations for infectious disease, targeted and not targeted, as well as from respiratory diseases in children in Rome.
Giuseppe La Torre   +6 more
doaj   +1 more source

Childhood vaccinations: A pilot study on knowledge, attitudes and vaccine hesitancy in pregnant women [PDF]

open access: yes, 2017
Background. The objective of this pilot study was to test a questionnaire aimed at assessing knowledge of and attitudes towards vaccination, as well as intention to vaccinate, among pregnant women. Methods.
Adamo, Giovanna   +9 more
core   +1 more source

Differential reactivity of SARS‐CoV‐2 S‐protein T‐cell epitopes in vaccinated versus naturally infected individuals

open access: yesClinical &Translational Immunology, Volume 14, Issue 5, May 2025.
We investigated the immunoreactivity of SARS‐CoV‐2 spike protein T‐cell epitopes in individuals who were SARS‐CoV‐2 naive, vaccinated with the AstraZeneca vaccine, and those who became naturally infected after vaccination. While the number of immunoreactive epitopes remained consistent across all groups, we observed a shift in T‐cell responses: naive ...
Daniel J Browne   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy